The Global Commission backs basic measures to protect drug takers and save money: providing clean needles, for instance, does not stop people taking the drug, but does stop them getting infected.

Still, the FDA found drug-treated patients did face about twice the risk: 0.43 percent of drug-treated patients experienced suicidal thoughts or behavior compared with 0.22 percent of placebo-takers.